Mission BioCapital Platinum Program 2023

Sponsored by Mission BioCapital, Eli Lilly and Company, & Ono Venture Investment



Lab space, seed capital, networking, and advice: Everything you need to launch your company!

Here at Mission BioCapital, we love working with entrepreneurs like you. We and our partner life science incubators are constantly developing new ways to provide a launchpad for world-changing science.

As biotech entrepreneurs, you have unique needs: You need lab space fitted with state-of-the-art research equipment; professional support staff who can manage everything from EH&S training to proper handling of biohazard waste; office space for meetings with your team and potential investors; and a vibrant, collaborative space in which to share ideas and expertise with other exciting life science companies.

You also need capital to pay for those critical early experiments, the lawyers, the rent, the insurance. You need expertise and advice on what those critical early experiments should be. You need perspective on defining a meaningful roadmap for an early-stage biotech company.

The Platinum Program was designed to meet all these needs! Together with our partners, we aim to find high-potential early-stage biomedical innovations powered by enthusiastic teams and back them for the best possible chance for success.

The Platinum Program 2023 will award four to six winning startup-ups with:

  • A guaranteed lab bench in one of Mission BioCapital’s affiliated incubators located in 13 cities in the U.S. and Europe
  • $500,000 of seed capital per awardee*
  • Strategic scientific and business development mentorship from experts across MBC’s corporate network, including sponsors Mission BioCapital, Eli Lilly, and Ono Venture Investment

*Opportunity for >$500,000 per award, depending on the quality of applications and at the sole discretion of Mission BioCapital. All awards will be made as SAFE investments.

Applications for the Mission BioCapital Platinum Program 2023 will go live on June 1, 2023. MBC will accept applications until August 15, 2023 and award Platinum Tickets to up to six companies in Fall 2023.


APPLICATIONS ARE NO LONGER BEING ACCEPTED FOR THE 2023 MISSION BIOCAPITAL PLATINUM PROGRAM. Please follow us on LinkedIn to learn when the 2024 Platinum Program will begin accepting applications.

If you have been selected as a finalist for the 2023 Platinum Program, you will receive an email notifying you in September. Finalists will be required to virtually pitch to the Mission BioCapital partnership on September 26th, 2023. Award decisions will be made thereafter.

Thank you for your interest in the Mission BioCapital Platinum Program!

Have questions about the Platinum Program and/or want to learn more about Mission BioCapital? Email platinumprogram@missionbiocapital.com.

Platinum Program application form

Our Platinum Program was designed to include everything you need to launch your company!

2023 awards will include up to $500,000* and a lab bench in one of our affiliated incubators located in 13 cities in the U.S. and Europe.

*Opportunity for >$500,000 per award, depending on the quality of applications and at the sole discretion of Mission BioCapital. All awards will be made as SAFE investments.

* Required field

PPA Form


If you have yet to incorporate a company, that’s OK! Our Platinum Program was designed to help you launch your company. Would you like help with that?


Please indicate which incubator location(s) you’re interested in (select at least one):


Please Note: Your response to the next question will not qualify/disqualify you for consideration in our process to award Platinum Tickets. Applications and pitches will be reviewed based on merit and other requirements for the program and not based on your answers to the following question. This information will be used only to help us ensure that we are running an equitable process.

Mission BioCapital strongly encourages under-represented founders to apply. If you identify as under-represented in the biotech industry please self-identify here*: (check all applicable boxes)

*While we know that checking boxes can never fully capture the complexity of your identity, the above options are included because they have been identified in peer-reviewed literature and reports as identities and demographics that are measurably under-represented in the biotech industry. This list is not meant to be exhaustive. There are many other identities and demographics that are not widely discussed as under-represented but that we believe are important to support.


Non-Confidential Presentation

Please upload a non-confidential presentation (10 slide maximum) that addresses the following points:

  • Clinical unmet need and addressable patient population
  • Competitive advantage over current state of the art
  • Proprietary aspect(s) & current state of any IP
  • Regulatory and reimbursement plans
  • Strongest data-to-date
  • Use of proceeds from the Platinum ticket
  • Team (management, Board of Directors, Scientific Advisory Board)

Maximum file size: 33.55MB

Select file from your computer. PDF format only. Size: up to 10 pages/slides.


News from Our Network

Follow us on twitter @MissionBioCap

Save the date for two big 2024 invite-only events this spring! Announcing the Tech Transfer Showcase with
(Feb 13), and another iteration of our hit BioLabs Investor Day series (April 16)

We’re very excited to have 16 NJ life science startups on the agenda for #biolabsinvestorday on Thursday! From pre-Seed to Series B, each company will get 5 minutes to give lightning pitches to a room full of other startups, investors, sponsors and partners.

Interested in pitching your biotech company to world-class investors? Join us for a packed day of curated networking and 5-minute pitches at BioLabs Investor Day on October 26! Pre-seed through Series B. Apply at http://wkf.ms/45MLTDn.